Lionel Carnot

Lionel Carnot is a prominent figure in the venture capital and biotechnology sectors. He currently serves as a Partner at Earlybird Venture Capital and is also a Managing Director at Bay City Capital. His career in venture capital began in 2005 when he joined Bay City Capital, where he has played a significant role in enhancing the firm's visibility in the European healthcare innovation landscape and the global life sciences community.14

Professional Background

• Education: Carnot holds an MBA with Distinction from INSEAD and an MS with honors in Molecular Biology from the University of Geneva.
• Previous Experience: Before joining Bay City Capital, he was a Principal at Oracle Partners, worked as a Product Manager for Prozac at Eli Lilly, and held various roles in sales and marketing at Sanofi-Aventis. He has also provided consulting services to the biopharmaceutical industry through firms like Booz Allen & Hamilton and Accenture.1

Current Roles

• Bay City Capital: As Managing Director, he oversees European operations and contributes to strategic investments in pharmaceuticals and diagnostics.
• Board Memberships: He serves on the Board of Directors for several companies, including Oculis SA and iStar Medical, and has previously held board positions at Merus N.V. and Madrigal Pharmaceuticals.14

LinkedIn Profile

Carnot is active on LinkedIn, where he has over 500 connections and shares insights related to his work in venture capital and healthcare innovation. His profile can be found under the username lionel-carnot-8742563.23